De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
China National Chemical Engineering Toekomstige groei
Future criteriumcontroles 1/6
China National Chemical Engineering zal naar verwachting groeien in winst en omzet met respectievelijk 11.2% en 9.4% per jaar. De winst per aandeel zal naar verwachting groeien met 11.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.7% zijn.
Belangrijke informatie
11.2%
Groei van de winst
11.2%
Groei van de winst per aandeel
| Construction winstgroei | 14.0% |
| Inkomstengroei | 9.4% |
| Toekomstig rendement op eigen vermogen | 9.7% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 10 Sep 2024 |
Recente toekomstige groei-updates
China National Chemical Engineering Co., Ltd Just Missed Revenue By 14%: Here's What Analysts Think Will Happen Next
Sep 03
China National Chemical Engineering Co., Ltd (SHSE:601117) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 02Recent updates
We Think China National Chemical Engineering (SHSE:601117) Can Stay On Top Of Its Debt
Sep 25China National Chemical Engineering Co., Ltd Just Missed Revenue By 14%: Here's What Analysts Think Will Happen Next
Sep 03China National Chemical Engineering Co., Ltd's (SHSE:601117) Low P/E No Reason For Excitement
Aug 28China National Chemical Engineering (SHSE:601117) Is Experiencing Growth In Returns On Capital
Jul 12We Think China National Chemical Engineering (SHSE:601117) Can Stay On Top Of Its Debt
Jun 15China National Chemical Engineering Co., Ltd (SHSE:601117) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 02Is China National Chemical Engineering Co., Ltd (SHSE:601117) Worth CN¥6.7 Based On Its Intrinsic Value?
Apr 12Return Trends At China National Chemical Engineering (SHSE:601117) Aren't Appealing
Mar 21Here's Why China National Chemical Engineering (SHSE:601117) Can Manage Its Debt Responsibly
Feb 29Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 226,992 | 7,110 | N/A | 9,837 | 10 |
| 12/31/2025 | 210,380 | 6,490 | N/A | 8,728 | 10 |
| 12/31/2024 | 193,165 | 5,867 | N/A | 7,145 | 9 |
| 6/30/2024 | 178,046 | 5,319 | 613 | 4,337 | N/A |
| 3/31/2024 | 180,715 | 5,532 | 4,772 | 8,385 | N/A |
| 12/31/2023 | 178,367 | 5,426 | 5,800 | 9,134 | N/A |
| 9/30/2023 | 168,706 | 5,418 | 563 | 4,517 | N/A |
| 6/30/2023 | 173,853 | 5,713 | 3,158 | 6,205 | N/A |
| 3/31/2023 | 165,022 | 5,549 | -675 | 2,360 | N/A |
| 12/31/2022 | 157,722 | 5,415 | -1,542 | 1,500 | N/A |
| 9/30/2022 | 167,360 | 5,486 | -3,150 | -77 | N/A |
| 6/30/2022 | 156,177 | 5,381 | -5,397 | -1,802 | N/A |
| 3/31/2022 | 147,649 | 4,825 | -6,435 | -2,486 | N/A |
| 12/31/2021 | 137,293 | 4,664 | -1,590 | 2,242 | N/A |
| 9/30/2021 | 133,410 | 3,640 | 425 | 3,201 | N/A |
| 6/30/2021 | 128,849 | 4,003 | 10,203 | 12,082 | N/A |
| 3/31/2021 | 121,024 | 3,802 | 11,063 | 12,112 | N/A |
| 12/31/2020 | 109,459 | 3,516 | 7,451 | 8,329 | N/A |
| 9/30/2020 | 106,733 | 3,390 | 3,112 | 4,123 | N/A |
| 6/30/2020 | 101,633 | 2,904 | 1,067 | 2,090 | N/A |
| 3/31/2020 | 99,276 | 2,968 | 812 | 1,833 | N/A |
| 12/31/2019 | 103,624 | 3,061 | 3,961 | 4,724 | N/A |
| 9/30/2019 | 90,753 | 2,752 | 4,069 | 5,052 | N/A |
| 6/30/2019 | 85,954 | 2,450 | -852 | 60 | N/A |
| 3/31/2019 | 84,246 | 2,154 | 1,393 | 2,335 | N/A |
| 12/31/2018 | 81,445 | 1,932 | 3,924 | 4,909 | N/A |
| 9/30/2018 | 73,848 | 1,890 | 4,006 | 5,313 | N/A |
| 6/30/2018 | 67,636 | 1,794 | 6,226 | 7,604 | N/A |
| 3/31/2018 | 62,975 | 1,647 | N/A | 4,240 | N/A |
| 12/31/2017 | 58,571 | 1,557 | N/A | 2,886 | N/A |
| 9/30/2017 | 54,906 | 1,620 | N/A | 1,062 | N/A |
| 6/30/2017 | 53,198 | 1,775 | N/A | 2,520 | N/A |
| 3/31/2017 | 52,539 | 1,698 | N/A | 1,993 | N/A |
| 12/31/2016 | 53,076 | 1,770 | N/A | 2,833 | N/A |
| 9/30/2016 | 55,307 | 2,402 | N/A | 3,233 | N/A |
| 6/30/2016 | 57,331 | 2,552 | N/A | 1,509 | N/A |
| 3/31/2016 | 59,074 | 2,692 | N/A | 2,682 | N/A |
| 12/31/2015 | 63,532 | 2,842 | N/A | 1,903 | N/A |
| 9/30/2015 | 63,312 | 2,477 | N/A | 1,845 | N/A |
| 6/30/2015 | 67,157 | 2,499 | N/A | 1,578 | N/A |
| 3/31/2015 | 70,326 | 3,018 | N/A | 2,063 | N/A |
| 12/31/2014 | 69,256 | 3,166 | N/A | 1,482 | N/A |
| 9/30/2014 | 67,461 | 3,438 | N/A | 513 | N/A |
| 6/30/2014 | 67,047 | 3,578 | N/A | 292 | N/A |
| 3/31/2014 | 63,769 | 3,417 | N/A | 553 | N/A |
| 12/31/2013 | 61,728 | 3,357 | N/A | 2,069 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 601117 ( 11.2% per jaar) ligt boven de spaarquote ( 2.9% ).
Winst versus markt: De winst van 601117 ( 11.2% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 23.2% per jaar).
Hoge groeiwinsten: De winst van 601117 zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van 601117 ( 9.4% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 13.2% per jaar).
Hoge groei-inkomsten: De omzet van 601117 ( 9.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 601117 zal naar verwachting over 3 jaar laag zijn ( 9.7 %).